Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 5:19 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 25,172 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: PRE Clear all

Conditions: NSCLC
Interventions: Atezolizumab, Tiragolumab; Drug
Lead sponsor: Alliance Foundation Trials, LLC.; Other
Eligibility: 18 Years and older
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 15
States / cities: La Jolla, California • Oakland, California • Roseville, California + 11 more

Conditions: Lower Respiratory Tract Infection, Pneumonia, Asthma, Bronchiolitis, Viral
Interventions: ED Clinical Decision Support (CDS-ED), Transitions Clinical Decision Support (CDS-Tr); Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 6 Months to 17 Years
Enrollment: 2,800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: Oakland, California • San Francisco, California • Nashville, Tennessee

Conditions: Developmental Language Disorders
Interventions: Grammar Treatment; Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 8 Years to 11 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 4
States / cities: Tucson, Arizona • Athens, Ohio • Logan, Utah + 1 more

Conditions: Healthy Volunteers
Interventions: Cold exposure, Normal temperature, Fixed diet, Ad libitum diet, Fasting; Other
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 55 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Sodium Excess, Racial Disparities, Blood Pressure, Cardiovascular Risk Factor
Interventions: Low Sodium Meal (140 mg sodium chloride), High Sodium Meal (2500 mg sodium chloride); Other
Lead sponsor: Indiana University; Other
Eligibility: 19 Years to 75 Years
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Auburn, Alabama • Bloomington, Indiana

Conditions: Opioid Use, Unspecified
Interventions: Opioid naive, At-risk for long term use, Long-term opioid recipient; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Rotator Cuff Tears
Interventions: Indocyanine Green; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Post-menopause
Interventions: Study Procedures; Other
Lead sponsor: Emory University; Other
Eligibility: 45 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 4
States / cities: Atlanta, Georgia

Conditions: Lung Cancer
Interventions: Questionnaire, Telephone Interactive System, Blood Samples; Behavioral · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2010
U.S. locations: 4
States / cities: Miami, Florida • Houston, Texas

Conditions: Diffuse Midline Glioma, Diffuse Midline High-grade Glioma, Medulloblastoma, Ependymoma
Interventions: PEP-CMV vaccine, Tetanus booster, Nivolumab, Temozolomide; Biological · Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 4 Years to 25 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2051
U.S. locations: 3
States / cities: St Louis, Missouri • Durham, North Carolina • Houston, Texas

Conditions: Vaping, Nicotine Dependence
Interventions: Double Blind Varenicline, Double Blind Placebo, QuitVaping, This Is Quitting; Drug · Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 16 Years to 25 Years
Enrollment: 261 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypospadias
Interventions: Decision Aid Website; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 0 Years to 5 Years · Male only
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Indianapolis, Indiana • Chapel Hill, North Carolina

Conditions: Hepatitis C Virus (HCV) Infection
Interventions: Community health worker (CHW)/ registered nurse (RN) [CHW/RN], Clinic-based Standard of Care (cbSOC) Program (control group); Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 7
States / cities: Los Angeles, California

Conditions: Post Traumatic Stress Disorder PTSD
Interventions: Prolonged Exposure Therapy, Cognitive Processing Therapy, Written Exposure Therapy, Shared Decision Making (SHARE); Behavioral · Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Fort Hood, Texas • San Antonio, Texas

Conditions: Stroke
Interventions: OPUS-i algorithm; Other
Lead sponsor: Temple University; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Camden, New Jersey • Philadelphia, Pennsylvania

Conditions: HIV
Interventions: Prepmate; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 29 Years · Male only
Enrollment: 121 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Delayed Ejaculation
Interventions: TENS penile nerve stimulation; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Medication Adherence, Substance Abuse, Intravenous, Risk Behavior, Hepatitis A, Hepatitis B, Hepatitis C
Interventions: Hepatitis A & B vaccine, Outreach, AIC, SEP; Biological · Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 14 Years to 29 Years
Enrollment: 546 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Head and Neck Cancer
Interventions: oxaliplatin, pemetrexed disodium; Drug
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 7
States / cities: Owensboro, Kentucky • Paducah, Kentucky • Jackson, Tennessee + 1 more

Conditions: Medication Adherence, High Blood Pressure, Diabetes
Interventions: Comparison to peers, Adherence feedback, Electronic pill bottle; Behavioral · Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetic Macular Edema, Cataract
Interventions: Bevacizumab, Ranibizumab, Aflibercept, Ozurdex; Drug
Lead sponsor: Bay Area Retina Associates; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Walnut Creek, California

Conditions: Hypoactive Sexual Desire Disorder
Interventions: Placebo, 0.5 mgTestosterone + 10 mg Buspirone; Drug
Lead sponsor: Emotional Brain NY Inc.; Industry
Eligibility: 21 Years to 70 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 10
States / cities: San Diego, California • Bradenton, Florida • Orlando, Florida + 7 more

Conditions: Lumbar Spine Disease, Lumbar Disc Herniation, Lumbar Spinal Stenosis
Interventions: Preoperative fluoroscopically-guided dorsal ramus block placed by the operative neurosurgeon; Procedure
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 232 participants
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Interventions: Biopsy, Biospecimen Collection, Computed Tomography, Echocardiography, Gilteritinib, Magnetic Resonance Imaging, Questionnaire Administration; Procedure · Drug · Other
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Ann Arbor, Michigan

Search by objective public record fields.

Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC

Reducing Overuse of Antibiotics With Decision Support

Treating Passive Structure Knowledge Deficits in School-Age Children With Developmental Language Disorder

Food Intake Response to Short-Term Modifications of Metabolism in Humans

Vascular Effects of Acute Sodium (VEAS) Study

Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase

Optimal Dosing of IC-Green for Visualization of Rotator Cuff Vascularity Using Advanced Imaging Modality Arthroscopy

Mental Stress Reactivity in Women With CMD

Longitudinal Study of Multiple Symptoms in Advanced Lung Cancer

PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma

Varenicline for Nicotine Vaping Cessation in Adolescents

Engaging Families to Improve the Care of Patients With Hypospadias

Development of a Community-based HCV Treatment Completion Intervention Among HCV Positive Homeless Adults

Shared Decision Making in PTSD Treatment

Optimizing the Prehospital Use of Stroke Systems of Care-Reacting to Changing Paradigms-Implementation (OPUS-i)

Enhancing PrEP in Community Settings (EPIC)

Penile Nerve Stimulation for Treatment of Delayed Ejaculation

A Randomized Trial of Vaccine Adherence in Young Injection Drug Users

Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer

Social Forces to Improve Statin Adherence (Study B)

Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification

Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder

Perioperative Local Anesthesia Block in Spine Surgery

Gilteritinib for the Treatment of ALK NSCLC